Literature DB >> 19193412

Radiolucent renal stones in children: combined use of shock wave lithotripsy and dissolution therapy.

Ibrahim A Mokhless1, Mostafa A Sakr, Hussein M Abdeldaeim, Mohamed M Hashad.   

Abstract

OBJECTIVES: To provide a noninvasive efficient modality for the treatment of radiolucent renal stones in children. Uric acid calculi comprise a significant proportion of urinary stones.
METHODS: This study included 24 children (10 girls and 14 boys) with radiolucent renal stones. Of the 24 patients, 5 presented with bilateral renal stones, 8 with multiple stones, 4 with staghorn stones, and 7 with a solitary renal stone. Their age range was 2-12 years (mean 6.3 +/- 2.8). The stone size range was 12-65 mm in the largest diameter. All patients were treated with combined extracorporeal shock wave lithotripsy (ESWL) and medical therapy in the form of urinary alkalization using potassium sodium hydrogen citrate and allopurinol for the treatment of hyperuricosuria. Before ESWL, 3 patients had a percutaneous nephrostomy tube inserted and 2 patients had a ureteral stent placed to relieve obstruction. ESWL was performed with a Siemens Lithostar using either general anesthesia or intravenous sedation. The follow-up period after stone clearance was 12-36 months (mean 26 +/- 7.2).
RESULTS: The stone-free rate of 100% was achieved in all 24 patients after 3 months of combined use of extracorporeal shock wave lithotripsy and dissolution therapy.
CONCLUSIONS: Combined ESWL and dissolution therapy accelerated stone clearance and delayed stone recurrence. The use of ESWL and medical therapy as a combined modality is a safe and effective treatment of radiolucent renal stones in children.

Entities:  

Mesh:

Year:  2009        PMID: 19193412     DOI: 10.1016/j.urology.2008.10.066

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  6 in total

1.  Optimal non-invasive treatment of 1-2.5 cm radiolucent renal stones: oral dissolution therapy, shock wave lithotripsy or combined treatment-a randomized controlled trial.

Authors:  Mohammed A Elbaset; Abdelwahab Hashem; Ahmed Eraky; Mohammed A Badawy; Ahmed El-Assmy; Khaled Z Sheir; Ahmed A Shokeir
Journal:  World J Urol       Date:  2019-04-03       Impact factor: 4.226

Review 2.  Urolithiasis: evaluation, dietary factors, and medical management: an update of the 2014 SIU-ICUD international consultation on stone disease.

Authors:  Helene Jung; Sero Andonian; Dean Assimos; Timothy Averch; Petrisor Geavlete; Yasuo Kohjimoto; Andreas Neisius; Joe Philip; Alberto Saita; Hemendra Shah; Palle Jörn Osther
Journal:  World J Urol       Date:  2017-02-03       Impact factor: 4.226

3.  Percutaneous nephrolithotomy for the treatment of radiolucent renal stones in children: is it different opaque stone treatment?

Authors:  Şenol Adanur; Tevfik Ziypak; Ahmet Ali Sancaktutar; Abdülkadir Tepeler; Berkan Reşorlu; Haluk Söylemez; Mansur Dağgülli; İsa Özbey; Ali Unsal
Journal:  Urolithiasis       Date:  2013-10-18       Impact factor: 3.436

4.  Treatment of renal uric acid stone by extracorporeal shock wave lithotripsy combined with sodium bicarbonate: 2 case reports.

Authors:  Hao-Yong Li; Pei-Yu Lian; Zhi-Yan Zhou; Peng Song; Yi Yan; Ji-Hong Liu
Journal:  Int J Clin Exp Med       Date:  2015-08-15

5.  Oral dissolution therapy for renal radiolucent stones, outcome, and factors affecting response: A prospective study.

Authors:  Shady Mohammed Salem; Mohammed Farag Sultan; Atef Badawy
Journal:  Urol Ann       Date:  2019 Oct-Dec

6.  Efficacy of potassium polycitrate on renal stone and microlithiasis predisposed by metabolic disorders.

Authors:  Hadi Sorkhi; Nazanin Saeedizand; Mohammad Poornasrollah; Ali Bijani; Hamid Shafi
Journal:  Caspian J Intern Med       Date:  2017
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.